Related Experiment Videos

Japan Carotid Atherosclerosis Study: JCAS

Shunro Endo1, Naoya Kuwayama, Yutaka Hirashima

  • 1Department of Neurosurgery, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan. sendo@ms.toyama-mpu.ac.jp

Neurologia Medico-Chirurgica
|June 10, 2004
PubMed

Insights

Carotid endarterectomy effectively reduces stroke risk in high-grade carotid artery stenosis. The Japan Carotid Atherosclerosis Study investigates this for Japanese patients, considering new stent treatments.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Clinical Trials

Background:

  • Previous trials (North American Symptomatic Carotid Endarterectomy Trial, European Carotid Surgery Trial, Asymptomatic Carotid Atherosclerosis Study) established carotid endarterectomy efficacy for high-grade carotid artery stenosis.
  • Limited data exists on Japanese populations regarding carotid artery stenosis treatment.
  • Advancements in endovascular stent treatment necessitate updated treatment guidelines.

Purpose of the Study:

  • To analyze current practices for treating carotid artery stenosis in Japan.
  • To propose evidence-based treatment guidelines for Japanese patients.
  • To evaluate the effectiveness of carotid endarterectomy and endovascular stenting in this population.

Main Methods:

  • Prospective, multicenter, non-randomized trial design.
  • Inclusion of 565 patients registered until January 2004.
  • Data collection on patient characteristics, treatment received, and outcomes.

Main Results:

  • Early results from 565 patients are presented.
  • Analysis of current treatment practices in Japan.
  • Baseline data for developing treatment guidelines.

Conclusions:

  • The Japan Carotid Atherosclerosis Study provides crucial data for Japanese patients with carotid artery stenosis.
  • Findings will inform the development of specific treatment guidelines for this population.
  • The study addresses the need for localized evidence in light of global trial data and technological advancements.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...